Nexalin Technology

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NXL and other ETFs, options, and stocks.

About NXL

Nexalin Technology, Inc. designs and develops neurostimulation products. Its medical devices help people with mental health illness. 

CEO
Mark White
CEOMark White
Employees
6
Employees6
Headquarters
Houston, Texas
HeadquartersHouston, Texas
Founded
2010
Founded2010
Employees
6
Employees6

NXL Key Statistics

Market cap
19.79M
Market cap19.79M
Price-Earnings ratio
-1.47
Price-Earnings ratio-1.47
Dividend yield
—
Dividend yield—
Average volume
86.04K
Average volume86.04K
High today
$1.18
High today$1.18
Low today
$1.12
Low today$1.12
Open price
$1.16
Open price$1.16
Volume
51.89K
Volume51.89K
52 Week high
$4.49
52 Week high$4.49
52 Week low
$0.591
52 Week low$0.591

People also own

Based on the portfolios of people who own NXL. This list is generated using Robinhood data, and it’s not a recommendation.
Calidi Biotherapeutics
BioVie
Aligos Therapeutics
Reviva Pharmaceuticals
Mobileye Global
Innoviz Technologies
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.